• Skip to main content
BC

biochimica clinica

en_US English
en_US English it_IT Italian
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

RASSEGNE - Reviews

Volume:

Biochimica Clinica 2022; 46(2) 096-116

Pubblicato on-line:

January 26, 2022

DOI:

10.19186/BC_2022.001

Scarica in PDF:

Varianti instabili dell’emoglobina: una sfida per il Laboratorio?
Unstable hemoglobin variants: a challenge for the laboratory?

AUTORI

Giuseppina Barberio1, Giovanni Ivaldi2
1UOC Medicina di Laboratorio, Ospedale di Treviso, ULSS2 Marca trevigiana, Treviso
2Già Laboratorio di Genetica Umana, Ospedali Galliera, Genova

ABSTRACT

Unstable hemoglobin variants: a challenge for the laboratory?

The unstable variants represent a subset of rare or very rare defects in the heterogeneous area of hemoglobinopathies; however they constitute a very important group of variants for the related clinical aspects. They exhibit a variety of manifestations that are characterized in many cases by more or less important hemolytic anemias able to attract the attention of clinicians. Actually, the signs produced by the reduced survival of erythrocytes in an adult or often in a child, can have different origins, being the consequence of an alteration of the structure of the erythrocyte membrane, produced by enzymatic or other defects. More than 150 hemoglobin variants, because of their in vitro and/or in vivo behavior, are generically classified as unstable and can potentially produce hemolytic anemia in various conditions and forms. Generally, a single amino acid substitution can produce an alteration in the primary structure of hemoglobin that promotes the formation of insoluble precipitates within the red blood cells and thus a hemolytic effect. For these particular diseases, the role of the laboratory is essential to differentiate and characterize the causes of the hemolytic anemias. The laboratory contributes to the diagnosis at different levels utilizing continuously evolving methodologies, while m

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967